Prescription drug · NDA
Epivir (Lamivudine) NDC 49702-204
Lamivudine 300 mg/1 · Tablet, Film coated · Oral · ViiV Healthcare Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 49702-204-13 | 4970202041349702020413 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-204-13)Marketed from Oct 4, 2010 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Epivir
- Generic name (nonproprietary)
- lamivudine
- Active ingredients
- Lamivudine — 300 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- ViiV Healthcare CompanyNDC labeler code 49702
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020564
- Marketing start
- Listing expires
- Other FDA classes
- Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
- Identifiers
- Product ID 49702-204_38eff3e4-ae02-40be-9f8a-5e2d99113447SPL ID 38eff3e4-ae02-40be-9f8a-5e2d99113447
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N449702020413followed by a unit qualifier and the quantityPackage 49702-0204-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 49702-204
- What is NDC 49702-204?
- 49702-204 is the product NDC for Epivir (lamivudine), Lamivudine 300 mg/1 tablet, film coated, listed with the FDA by ViiV Healthcare Company. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Epivir (Lamivudine).
- What is the active ingredient?
- Lamivudine.
- Who is the labeler?
- ViiV Healthcare Company, NDC labeler code 49702. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Epivir?
- 2 other product NDCs are listed under this name. See all Epivir NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Epivir products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Epivirlamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | ViiV Healthcare Company | 49702-203 | 49702-0203-18 |
| Epivirlamivudine | Lamivudine 10 mg/mL | SolutionOral | ViiV Healthcare Company | 49702-205 | 49702-0205-48 |
Other NDCs under NDA 020564
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Epivirlamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | ViiV Healthcare Company | 49702-203 |